Pharmacopsychiatry 2011; 44(07): 344-346
DOI: 10.1055/s-0031-1284425
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Partial Status Epilepticus after Electroconvulsive Therapy and Medical Treatment with Bupropion

R. Dersch
1   Department of Neurology, University Hospital Freiburg, Freiburg, Germany
,
S. Zwernemann
2   Department of Psychiatry and Psychotherapy, University Hospital Freiburg, Freiburg, Germany
,
U. Voderholzer
2   Department of Psychiatry and Psychotherapy, University Hospital Freiburg, Freiburg, Germany
3   Schön Klinik Roseneck, Prien am Chiemsee, Germany
› Author Affiliations
Further Information

Publication History

received 16 December 2010
revised 14 June 2011

accepted 28 June 2011

Publication Date:
06 October 2011 (online)

Abstract

Electroconvulsive therapy (ECT) is the most effective treatment for therapy-refractory depression. Usually, prior antidepressant medication will be continued during ECT. However, the seizure threshold may be influenced by psychotropic drugs. We report a patient who received right unilateral ECT under concomitant treatment with bupropion, a selective noradrenaline- and dopamine-reuptake inhibitor. After the fourth session, a focal status epilepticus occurred, which was pharmacoresistant for the duration of 12 days. We assume that the induction of a status may be facilitated by a lowering of the seizure threshold due to bupropion. An evaluation of drug therapy and control of EEG before and during ECT are recommended, especially when the drug treatment has an influence on the seizure threshold.

 
  • References

  • 1 Sheehan DV, Welch JB, Fishman SM. A case of bupropion-induced seizure. J Nerv Ment Dis 1986; 174: 496-498
  • 2 Dhillon S, Yang LPH, Curran MP. Bupropion – a review of its use in the management of major depressive disorder. Drugs 2008; 68: 653-689
  • 3 Fava M, Rush AJ, Thase ME et al. 15 years of clinical experience with bupropion HCL: From bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 2005; 7: 106-113
  • 4 Povlsen U, Wildschiødtz G, Høgenhaven H et al. Nonconvulsive status epilepticus after electroconvulsive therapy. J ECT 2003; 19: 164-169
  • 5 Baghai T, Marcuse A, Brosch M et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 2006; 7: 82-90
  • 6 Lisanby SH, Resor SR, Nobler MS et al. ECT in the treatment of status epilepticus. J ECT 2001; 17: 210-215
  • 7 Figiel GS, Jarvis MR. Electroconvulsive therapy in a depressed patient receiving bupropion. J Clin Psychopharmacol 1990; 10: 376
  • 8 Conway CR, Nelson LA. The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity. J ECT 2001; 17: 216-218
  • 9 Kellner CH, Pritchett JT, Jackson CW. Bupropion coadministration with electroconvulsive therapy: two case reports. J Clin Psychopharmacol 1994; 14: 215-216
  • 10 Patel AS, Gorst-Unsworth C, Venn RM et al. Anesthesia and electroconvulsive therapy: a retrospective study comparing etomidate and propofol. J ECT 2006; 22: 179-183
  • 11 Khalid N, Atkins M, Kirov G. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. J ECT 2006; 22: 184-188
  • 12 Rassmussen KG, Lunde ME. Patients who develop epilepsy during extended treatment with electroconvulsive therapy. Seizure 2007; 16: 266-270
  • 13 Fink M, Petrides G, Kellner C et al. Change in seizure threshold during electroconvulsive therapy. J ECT 2008; 24: 114-116
  • 14 Devinsky O, Duchowny MS. Seizure after convulsive therapy: a retrospective case survey. Neurology 1983; 33: 921-925